https://www.selleckchem.com/pr....oducts/ly2835219.htm
The AUC values from baseline to 8 h after administration in groups treated with 100 and 200 µg/kg of medetomidine were significantly lower in both the left and right eyes compared to the control group. The linear regression of the AUC values was significant for both eyes. Our results indicated that the intramuscular administration of medetomidine in rats decreased tear flow significantly in a dose-dependent manner.INTRODUCTION Type-2 diabetes mellitus (T2DM) is associated with early and severe atherosclerosis. However, few biomarkers